Syncona Limited NPV (SYNC)

Sector:

Investment Firms

Index:

FTSE 250

122.40p
   
  • Change Today:
    -0.40p
  • 52 Week High: 162.20
  • 52 Week Low: 106.20
  • Currency: UK Pounds
  • Shares Issued: 655.48m
  • Volume: 380,202
  • Market Cap: £802.30m
  • RiskGrade: 291

Syncona NAV falls in Q3

By Iain Gilbert

Date: Tuesday 07 Feb 2023

LONDON (ShareCast) - (Sharecast News) - Healthcare company Syncona said on Tuesday that net assets had fallen in the three months ended 31 December, principally due to the declining value of its quoted holdings and foreign exchange fluctuations.
Syncona stated net assets were £1.29bn at the end of the 2022, down from £1.36bn on 30 September, or 192.6p on a per share basis, leaving the group with a negative net asset value return of -5.1% in the quarter and -1.0% in the nine months to 31 December.

The London-listed group said shares in its Autolus Therapeutics investment declined following a $163.9m fundraising, shares in Achilles Therapeutics fell following the presentation of clinical data, and Freeline Therapeutics stock was impacted by market sentiment and delays across its programmes. Syncona's life science portfolio was valued at £641.1m, up from £602.6m.

Performance was also said to have been impacted by negative movements in foreign exchange, with the US dollar depreciating by 8.2% against Sterling, contributing to a -£48.5m negative impact on NAV.

Chief executive Chris Hollowood said: "The difficult financing conditions and uncertainties facing the biotech market continue to be very challenging. Syncona's hands-on approach and strategic balance sheet mean that we are well positioned to navigate this cycle.

"Whilst we anticipate financing conditions to remain difficult in 2023, our strategy of creating companies to develop products with dramatic efficacy has the potential to create fundamental value and we have a number of key milestones in the year ahead."

As of 0930 GMT, Syncona shares were untraded at 180.0p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SYNC Market Data

Currency UK Pounds
Share Price 122.40p
Change Today -0.40p
% Change -0.33 %
52 Week High 162.20
52 Week Low 106.20
Volume 380,202
Shares Issued 655.48m
Market Cap £802.30m
RiskGrade 291

SYNC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
60.81% above the sector average60.81% above the sector average60.81% above the sector average60.81% above the sector average60.81% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
24.92% below the sector average24.92% below the sector average24.92% below the sector average24.92% below the sector average24.92% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
87.46% below the sector average87.46% below the sector average87.46% below the sector average87.46% below the sector average87.46% below the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SYNC Dividends

  Latest Previous
  Final Final
Ex-Div 21-Jun-18 20-Jul-17
Paid 30-Jul-18 23-Aug-17
Amount 2.30p 2.30p

Trades for 28-Mar-2024

Time Volume / Share Price
14:31 5 @ 122.40p
14:30 4 @ 122.40p
14:29 1,032 @ 122.63p
14:29 1,200 @ 122.63p
14:23 229 @ 123.60p

SYNC Key Personnel

Chair Melanie Gee

Top of Page